AHL
INMB icon

Abel Hall LLC’s INmune Bio INMB Stock Holding History

Abel Hall LLC’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
+24,559
New +$34K 0.01% 907

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Abel Hall LLC's INMB Position: Q2 2026 in Review

Abel Hall LLC opened a new position in INmune Bio (INMB) in Q2 2026: 24,559 shares worth $40K. The stake represents 0.01% of the portfolio and ranks #907 among its holdings.

13 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Abel Hall LLC held 24,559 shares of INmune Bio worth $40K as of Q2 2026.
  • INmune Bio was a new Abel Hall LLC position in Q2 2026.
  • INmune Bio made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #907 holding.
  • 13 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.